Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR1405-01 for Postoperative Orthopedic Pain
CTR20242044Phase 2Completed
- Sponsor
- Nanjing Hairong Pharmaceutical Technology
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HR1405-01 in postoperative pain, sponsored by Nanjing Hairong Pharmaceutical Technology. Started Jun 2024; status: completed.
02
Drugs
HR1405-01
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20242044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242044.